Vonoprazan: First Global Approval-Reference-Cited by-同舟云学术

Vonoprazan: First Global Approval

Published:2015-03 Issue:4 Volume:75 Page:439-443
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Garnock-Jones Karly P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-015-0368-z.pdf

Reference17 articles.

1. Sachs G, Shin JM, Hunt R. Novel approaches to inhibition of gastric acid secretion. Curr Gastroenterol Rep. 2010;12(6):437–47.

2. Luo HJ, Deng WQ, Zou K. Protonated form: the potent form of potassium-competitive acid blockers. PLoS One. 2014;9(5):e97688.

3. Shin JM, Inatomi N, Munson K, et al. Characterization of a novel potassium-competitive acid blocker of the gastric H, K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438). J Pharmacol Exp Ther. 2011;339(2):412–20.

4. Takeda. New drug application approval of TAKECAB® for the treatment of acid-related diseases in Japan (media release). 26 Dec 2014. http://www.takeda.com .

5. Takeda. Takeda submits a new drug application for TAK-438 in Japan for the treatment of acid-related diseases (media release). 28 Feb 2014. http://www.takeda.co.jp .

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factorial design-aided derivatization-free fluorimetric ultrasensitive assay of vonoprazan with application in uniformity of dosage units and plasma samples analysis: Comprehensive and comparative greenness and whiteness assessment;Microchemical Journal;2024-10

2. Efficacy and safety of Vonoprazan-based treatment of Helicobacter pylori infection: a systematic review and network meta-analysis;BMC Infectious Diseases;2024-09-11

3. An Improved and Practical Synthesis of Vonoprazan;Organic Preparations and Procedures International;2024-09-09

4. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15

5. A scientometrics analysis and visualization of refractory gastroesophageal reflux disease;Frontiers in Pharmacology;2024-07-30